MX2023008533A - Derivados de glicoaminoacidos ciclicos. - Google Patents

Derivados de glicoaminoacidos ciclicos.

Info

Publication number
MX2023008533A
MX2023008533A MX2023008533A MX2023008533A MX2023008533A MX 2023008533 A MX2023008533 A MX 2023008533A MX 2023008533 A MX2023008533 A MX 2023008533A MX 2023008533 A MX2023008533 A MX 2023008533A MX 2023008533 A MX2023008533 A MX 2023008533A
Authority
MX
Mexico
Prior art keywords
skin
treatment
hair
prevention
regeneration
Prior art date
Application number
MX2023008533A
Other languages
English (en)
Inventor
Lénaïg Lopes
GODEFROY Géraldine DELIENCOURT
Jocelyne Legoedec
Original Assignee
Tfchem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tfchem filed Critical Tfchem
Publication of MX2023008533A publication Critical patent/MX2023008533A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02—Acyclic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/06—Heterocyclic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18—Acyclic radicals, substituted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/10—General cosmetic use

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Laser Surgery Devices (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a compuestos de la siguiente Fórmula (I): (ver Fórmula) (I), así como a su proceso de preparación; su uso en aplicaciones cosméticas o dermatológicas, en particular para a el tratamiento y/o prevención del envejecimiento de la piel, protección de la piel o regeneración de la piel; para el relleno de la piel y/o voluminización de la piel y/o densificación de la piel , y/o relleno de arrugas y/o humectación de la piel o el cabello y/o relipidización de la piel o el cabello y/o estimulación del crecimiento del cabello; para el tratamiento de piel seca y/o dermatitis atópica y/o eccema y/o psoriasis; para el tratamiento y/o prevención de una enfermedad de fibrosis (por ejemplo, una cicatriz excesiva tal como una cicatriz queloide o hipertrófica) o para la cicatrización; o para el tratamiento de la inflamación (por ejemplo, inflamación crónica, de bajo grado); y su uso como adyuvante para la conservación y/o protección y/o regeneración de un material biológico o un microorganismo.
MX2023008533A 2021-01-20 2022-01-20 Derivados de glicoaminoacidos ciclicos. MX2023008533A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP21305070 2021-01-20
PCT/EP2022/051208 WO2022157233A1 (en) 2021-01-20 2022-01-20 Cyclic glycoaminoacid derivatives

Publications (1)

Publication Number Publication Date
MX2023008533A true MX2023008533A (es) 2023-07-28

Family

ID=74505159

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023008533A MX2023008533A (es) 2021-01-20 2022-01-20 Derivados de glicoaminoacidos ciclicos.

Country Status (10)

Country Link
US (1) US20240124510A1 (es)
EP (1) EP4281466A1 (es)
JP (1) JP2024504135A (es)
KR (1) KR20230133329A (es)
CN (1) CN117222655A (es)
AU (1) AU2022210386A1 (es)
CA (1) CA3208272A1 (es)
IL (1) IL304552A (es)
MX (1) MX2023008533A (es)
WO (1) WO2022157233A1 (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5855897A (en) 1996-09-13 1999-01-05 E-L Management Corp. Topical composition and method for enhancing lipid barrier synthesis
FR2878851B1 (fr) 2004-12-02 2007-02-09 Inst Nat Sciences Appliq Composes c-glycopeptides gem-difluores, leur preparation et leur utilisation en cryochirurgie et/ou cryopreservation
FR2900656A1 (fr) 2006-05-03 2007-11-09 Inst Nat Sciences Appliq Composes c-glycopeptides gem-difluores, leur preparation et leur utilisation notamment pour la preservation de materiaux biologiques
JP5934246B2 (ja) 2010-12-22 2016-06-15 テーエフシム グリコ−ｃｆ２−セリンおよびグリコ−ｃｆ２−トレオニンの誘導体
EP3119800B9 (en) 2014-03-17 2021-06-09 Tfchem Glycopeptide derivatives for the preservation and protection of biological materials and microorganisms
WO2018138541A1 (en) 2017-01-30 2018-08-02 Tfchem Glycopeptide derivatives for use in the treatment and/or prevention and/or attenuation of fibrosis diseases

Also Published As

Publication number Publication date
CN117222655A (zh) 2023-12-12
AU2022210386A1 (en) 2023-08-17
JP2024504135A (ja) 2024-01-30
EP4281466A1 (en) 2023-11-29
WO2022157233A1 (en) 2022-07-28
US20240124510A1 (en) 2024-04-18
IL304552A (en) 2023-09-01
CA3208272A1 (en) 2022-07-28
KR20230133329A (ko) 2023-09-19

Similar Documents

Publication Publication Date Title
US20150216784A1 (en) Cosmetic composition containing fragments of bacterial cellulose film and method for manufacturing thereof
CN111278326A (zh) 改善皮肤、头发和头皮健康的基于酵母的面膜
KR101349248B1 (ko) 탈수소 아비에틱산을 유효성분으로 함유하는 항노화용 조성물
WO2011121250A3 (fr) Composition cosmetique et pharmaceutique comprenant de la n-acetyl-glucosamine- 6 - phosphate
CN106389171A (zh) 一种纯植物的天然成分复合纯露系列爽肤水及制作方法
KR20200031665A (ko) 외용 조성물
MX2023001789A (es) Composiciones naturales para el cuidado de la piel.
KR20090038648A (ko) 편백 오일를 함유한 여드름 피부용 화장료 조성물
AU2016408303A1 (en) A composition for skin and/or hair care and/or treatment
MX2023008533A (es) Derivados de glicoaminoacidos ciclicos.
KR20170038581A (ko) Aha, 우레아, 및 니아신아마이드를 포함하는 각질 연화용 및 미백용 화장료 조성물
WO2012049697A1 (en) Preparation for antiwrinkle treatment based on caffeine micro - patches beta-glucan polysaccarides
CN114642623A (zh) 一种皮肤抗菌修复功能液及其制备方法和应用
KR102087655B1 (ko) 탈수소 아비에틱산과 트랜스 쿠미닉산의 혼합물을 함유하는 항노화용 조성물
KR20160025952A (ko) 피부트러블 개선용 화장료 조성물
KR102487267B1 (ko) 아스타잔틴 복합 성분을 유효성분으로 포함하는 항염증용 화장료 조성물
KR20130130421A (ko) 트랜스 쿠미닉산을 유효성분으로 함유하는 항노화용 조성물
KR102485135B1 (ko) 아스타잔틴 복합 성분을 유효성분으로 포함하는 다기능성 화장료 조성물
KR102072947B1 (ko) 상처치유 또는 피부재생 촉진용 약학 조성물
AU2018451357B2 (en) Personal care compositions
KR102093884B1 (ko) 피부성장인자 및 사이토카인을 유효성분으로 포함하는 피부 항노화용 조성물
US20230285257A1 (en) Cosmetic composition
CN113069392A (zh) 一种抗蓝光护肤组合物及应用
KR20180037269A (ko) 피부병의 종합적 치료에서의 화장품 및/또는 의약품으로서의 박테리오로돕신의 용도
KR20160064704A (ko) 이카리시드 b6를 유효성분으로 함유하는 항염증용 및 항아토피용 조성물